These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2903379)

  • 1. Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism.
    Laron Z; Klinger B; Erster B; Anin S
    Lancet; 1988 Nov; 2(8621):1170-2. PubMed ID: 2903379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I.
    Laron Z; Klinger B; Blum WF; Silbergeld A; Ranke MB
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):301-4. PubMed ID: 1373347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature.
    Laron Z; Suikkari AM; Klinger B; Silbergeld A; Pertzelan A; Seppälä M; Koivisto VA
    Acta Endocrinol (Copenh); 1992 Oct; 127(4):351-8. PubMed ID: 1280392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Wilton P
    Acta Paediatr Suppl; 1992 Sep; 383():137-42. PubMed ID: 1281024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism.
    Laron Z; Klinger B; Jensen LT; Erster B
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):145-50. PubMed ID: 1934530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism.
    Laron Z; Anin S; Klipper-Aurbach Y; Klinger B
    Lancet; 1992 May; 339(8804):1258-61. PubMed ID: 1349669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism).
    Walker JL; Ginalska-Malinowska M; Romer TE; Pucilowska JB; Underwood LE
    N Engl J Med; 1991 May; 324(21):1483-8. PubMed ID: 2023608
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum prolactin in patients with Laron-type dwarfism: effect of insulin-like growth factor I.
    Silbergeld A; Klinger B; Schwartz H; Laron Z
    Horm Res; 1992; 37(4-5):160-4. PubMed ID: 1490658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A child with phenotypic Laron dwarfism and normal somatomedin levels.
    Pintor C; Loche S; Cella SG; Müller EE; Baumann G
    N Engl J Med; 1989 Feb; 320(6):376-9. PubMed ID: 2913494
    [No Abstract]   [Full Text] [Related]  

  • 10. An update on Laron syndrome.
    Laron Z
    Arch Dis Child; 1993 Mar; 68(3):345-6. PubMed ID: 8466235
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical use of somatomedin-1: yes or no?
    Laron Z
    Paediatr Drugs; 1999; 1(3):155-9. PubMed ID: 10937448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laron-type dwarfism with apparently normal high affinity serum growth hormone-binding protein.
    Buchanan CR; Maheshwari HG; Norman MR; Morrell DJ; Preece MA
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):179-85. PubMed ID: 1934534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador.
    Rosenbloom AL; Guevara Aguirre J; Rosenfeld RG; Fielder PJ
    N Engl J Med; 1990 Nov; 323(20):1367-74. PubMed ID: 2233903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A child with phenotypic Laron dwarfism and normal somatomedin levels.
    Laron Z; Silbergeld A
    N Engl J Med; 1989 Jun; 320(25):1698-9. PubMed ID: 2725626
    [No Abstract]   [Full Text] [Related]  

  • 15. [Laron type familial dwarfism; genetic primary somatomedin deficiency].
    Pierson M; Malaprade D; Fortier G; Belleville F; Lasbennes A; Wuilbereq L
    Arch Fr Pediatr; 1978 Feb; 35(2):151-64. PubMed ID: 637670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth-stimulating effects of somatomedin-/insulin-like peptides in Snell dwarf mice.
    van Buul-Offers S; Hoogerbrugge CM; Branger J; Feijlbrief M; Van den Brande JL
    Horm Res; 1988; 29(5-6):229-36. PubMed ID: 3220460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissues of the Laron dwarf are sensitive to insulin-like growth factor I but not to growth hormone.
    Geffner ME; Golde DW; Lippe BM; Kaplan SA; Bersch N; Li CH
    J Clin Endocrinol Metab; 1987 May; 64(5):1042-6. PubMed ID: 3031118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism.
    Laron Z; Klinger B; Erster B; Silbergeld A
    Acta Endocrinol (Copenh); 1989 Oct; 121(4):603-8. PubMed ID: 2800930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body fat in Laron syndrome patients: effect of insulin-like growth factor I treatment.
    Laron Z; Klinger B
    Horm Res; 1993; 40(1-3):16-22. PubMed ID: 8300045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nutrient intake on growth, insulin-like growth factors, and their binding proteins in a Laron-type dwarf.
    Crosnier H; Gourmelen M; Prévot C; Rappaport R
    J Clin Endocrinol Metab; 1993 Jan; 76(1):248-50. PubMed ID: 7678425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.